However, ANGPTL2-mut#2-containing SEVs had no effects on B-ALL progression (Fig. 5a-d), which further indicated that ANGPTL2 was mainly secreted as SEVs in the BM niche to maintain leukemogenic activities. Here, ANGPTL2 is linked to precursor B-cell acute lymphoblastic leukemia.